Recombinant Human S100A5 Protein，His

S100A5 is a member of the S100 family of proteins, characterized by their calcium-binding properties and involvement in various cellular processes. It plays a crucial role in regulating cell cycle progression, differentiation, and apoptosis, and its expression is associated with several pathological conditions, including cancers and inflammatory diseases. Recent studies have highlighted S100A5 as a potential biomarker and therapeutic target due to its upregulation in certain tumors, indicating its involvement in tumorigenesis and cancer progression. The interest in recombinant S100A5 protein stems from its potential applications in understanding its role in these diseases, elucidating the molecular mechanisms underlying its functions, and exploring its potential as a target for novel therapeutic interventions. Recombinant S100A5 allows for the study of its biochemical properties, interactions with other proteins, and its physiological roles in a controlled environment, which can lead to insights into its mechanisms of action. Furthermore, understanding S100A5's interactions at the molecular level may pave the way for the development of S100A5-based diagnostic and therapeutic strategies. As research continues, S100A5's dual role in normal physiology versus disease pathology is likely to provide significant insights into both basic cellular function and potential clinical applications.